Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered

Abstract

The inv(16) and related t(16;16) are found in 10% of all cases with de novo acute myeloid leukemia. In these rearrangements the core binding factor β (CBFB) gene on 16q22 is fused to the smooth muscle myosin heavy chain gene (MYH11) on 16p13. To gain insight into the mechanisms causing the inv(16) we have analysed 24 genomic CBFB-MYH11 breakpoints. All breakpoints in CBFB are located in a 15-Kb intron. More than 50% of the sequenced 6.2 Kb of this intron consists of human repetitive elements. Twenty-one of the 24 breakpoints in MYH11 are located in a 370-bp intron. The remaining three breakpoints in MYH11 are located more upstream. The localization of three breakpoints adjacent to a V(D)J recombinase signal sequence in MYH11 suggests a V(D)J recombinase-mediated rearrangement in these cases. V(D)J recombinase-associated characteristics (small nucleotide deletions and insertions of random nucleotides) were detected in six other cases. CBFB and MYH11 duplications were detected in four of six cases tested.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Adriaansen HJ, Boekhorst te PAW, Hagemeijer AM, Schoot van der CE, Delwel HR and Dongen van JM. . 1993 Blood 81: 3043–3051.

  • Altschul SF, Gish W, Miller W, Myers EW and Lipman DJ. . 1990 J. Mol. Biol. 215: 403–410.

  • Castilla LH, Wijmenga C, Wang Q, Stacy T, Speck NA, Eckhaus M, Marin-Padilla M, Collins FS, Wynshaw-Boris A and Liu PP. . 1996 Cell 87: 687–696.

    Article  CAS  Google Scholar 

  • Claxton DF, Liu P, Hsu HB, Marlton P, Hester J, Collins F, Deisseroth AB, Rowley JD and Siciliano MJ. . 1994 Blood 83: 1750–1756.

  • Dauwerse JG, Van Ommen G-JB, Breuning MH and Pearson PL. . 1989 Nucleic Acids Res. 17: 3603.

  • Dauwerse JG, Wessels JW, Giles RH, Wiegant J, Raap AK, van der Reijden BA, Fugazza G, Jumelet EA, Smit E, Baas F, Hagemeijer A, Beverstock GC, van Ommen GJB and Breuning MH. . 1993 Hum. Mol. Genet. 2: 1527–1534.

  • Dong WF, Xu Y, Hu QL, Munroe D, Minowada J, Housman DE and Minden MD. . 1995 Leukemia 9: 1812–1817.

  • Gellert M. . 1992 TIG 8: 408–412.

  • Hébert J, Cayuela J-M, Daniel M-T, Berger R and Sigaux F. . 1994 Blood 84: 2291–2296.

  • Ito Y. . 1996 J. Cancer Res. Clin. Oncol. 122: 266–274.

  • Jurka J, Walichiewicz J and Milosavljevic A. . 1997 J. Mol. Evol. 35: 286–291.

  • Kuss BJ, Deeley RG, Cole SPC, Willman CL, Kopecky KJ, Wolman SR, Eyre HJ, Lane SA, Nancarrow JK, Whitmore SA and Callen DF. . 1994 Lancet 343: 1531–1534.

  • Le Beau MM, Larson RA, Bitter MA, Vardiman JW, Golomb HM and Rowley JD. . 1983 N. Engl. J. Med. 309: 630–636.

  • Liu P, Tarlé SA, Hajra A, Claxton DF, Marlton P, Freedman M, Siciliano MJ and Collins FS. . 1993 Science 261: 1041–1044.

    Article  CAS  Google Scholar 

  • Liu PP, Hajra A, Wijmenga C and Collins FS. . 1995 Blood 85: 2289–2302.

  • Marlton P, Claxton DF, Liu P, Estey EH, Beran M, LeBeau M, Testa JR, Collins FS, Rowley JD and Siciliano MJ. . 1995 Blood 85: 772–779.

  • Matsuoka R, Yoshida MC, Furutani Y, Imamamura S, Kanda N, Yanagisawa M, Masaki T and Takao A. . 1993 Am. J. Med. Genet. 46: 61–67.

    Article  CAS  Google Scholar 

  • Ogawa E, Inuzuka M, Maruyama M, Satake M, Naito-Fujimoto M, Ito Y and Shigesada K. . 1993 Virology 194: 314–331.

    Article  CAS  Google Scholar 

  • Ohno H, Doi S, Yabumoto K, Fukuhara S and McKeithan TW. . 1993 Leukemia 7: 2057–2063.

  • Papadopoulos PC, Greenstein AM, Gaffney RA, Westbrook CAI and Wiedemann LM. . 1990 Genes Chrom. Cancer 1: 233–239.

  • Poirel H, Radford-Weiss I, Rack K, Troussard X, Veil A, Valensi F, Picard F, Guesnu M, Leboeuf D, Melle J, Dreyfus F, Flandrin G and Macintyre E. . 1995 Blood 85: 1313–1322.

  • Schichman SA, Caligiuri MA, Strout MP, Carter SL, Gu Y, Canaani E, Bloomfield CD and Croce CM. . 1994 Cancer Res. 54: 4277–4280.

  • Shurtleff SA, Meyers S, Hiebert SW, Raimondi SC, Head DR, Willman CL, Wolman S, Slovak ML, Carroll AJ, Behm F, Hulshof MG, Motroni TA, Okuda T, Liu P, Collins FS and Downing JR. . 1995 Blood 85: 3695–3703.

  • Smit AFA and Riggs AD. . 1995a Nucl. Acids Res. 23: 98–102.

  • Smit AFA, Tóth G, Riggs AD and Jurka J. . 1995b J. Mol. Biol. 246: 401–417.

  • Speck NA and Stacy T. . 1995 Crit. Rev. Eukaryot Gene Expression 5: 337–364.

  • Van der Reijden BA, Dauwerse JG, Wessels JW, Beverstock GC, Hagemeijer A, van Ommen GJB and Breuning MH. . 1993 Blood 82: 2948–2952.

  • Van der Reijden BA, Lombardo M, Dauwerse HG, Giles RH, Mühlematter D, Jotterand Bellomo M, Wessels HW, Beverstock GC, van Ommen GJB, Hagemeijer A and Breuning MH. . 1995 Blood 86: 277–282.

  • Van der Reijden BA, Martinet D, Dauwerse HG, Giles RH, Wessels HW, Beverstock GC, Smit B, Jotterand Bellomo M, Mühlematter D, Lafage-Pochitaloff M, Reiffers J, Bilhou-Nabera C, van Ommen GJB, Hagemeijer A and Breuning MH. . 1996 Leukemia 10: 1459–1462.

  • Von Lindern M, Breems D, Van Baal S, Adriaansen H and Grosveld G. . 1992 Genes Chrom. Cancer 5: 227–234.

  • Wang S, Wang Q, Crute BE, Melnikova IN, Keller SR and Speck NA. . 1993 Mol. Cell. Biol. 13: 3324–3339.

    Article  CAS  Google Scholar 

  • Wijmenga C, Winokur ST, Skraastad MI, Altherr MR, Wasmuth JJ, Murray JC, Hofker MH and Frants RR. . 1993 Hum. Genet. 92: 198–203.

  • Yanagisawa K, Horiuchi T and Fujita S. . 1991 Blood 78: 451–457.

Download references

Acknowledgements

The authors thank Walter Heeroma for help in drafting and O Bruzzese, M Leeman and Dr C Castagné for their assistance in chromosome and FISH analysis of Swiss patients, the clinicians and the members of the Leukemia group (Chairman, U Hess) of the Swiss Institute for Applied Cancer Research/Swiss Group for Clinical Cancer Research for providing the Swiss patients. These studies were supported by the European Community sponsored Biomed concerted action for `Molecular Cytogenetic Diagnosis of Hematological Malignancies' CT941703 and the Dutch Cancer Society. Cytogenetic and FISH analyses performed in Lausanne, Switzerland, were supported by grants from the Ligue Suisse contre le Cancer (FOR 209), the Ligue Agrovienne contre le Cancer, the Cramer Foundation, the Swiss Institute for Applied Cancer Research/Swiss Group for Clinical Cancer Research, Leukemia Group, the Swiss national Science Foundation (31-32319.91), the Recherche Suisse contre le Cancer, and the Stiftung zur Krebsbekämpfung (Martine Jotterand Bellomo). The CBFB sequences presented in this report have been deposited in GenBank (accession numbers AF084955 – AF084970).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

van der Reijden, B., Dauwerse, H., Giles, R. et al. Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered. Oncogene 18, 543–550 (1999). https://doi.org/10.1038/sj.onc.1202321

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202321

Keywords

This article is cited by

Search

Quick links